PHOENIX, Feb. 15,
2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq:
SNES; "SenesTech" or the "Company"), the leader in fertility
control to manage animal pest populations, today announces entry
into a distribution agreement with Q-chem, a pest control product
supplier in The Netherlands.
"Q-chem is a perfect partner for SenesTech as we begin our
expansion into Europe, and Evolve™
fits into their portfolio perfectly. They have a stated focus on
new, environmentally friendly and sustainable products for pest
control, and they distribute pest control products in The Netherlands and
specifically non-biocidal products throughout Europe," said Joel
Fruendt, SenesTech's President and CEO.
"The Netherlands first
implemented an Integrated Pest Control (IPM) program four years ago
for Norwegian rats with the explicit goal of reducing the reliance
on anti-coagulant rodenticides. This is part of an overall European
Union goal to terminate the use of all anti-coagulants due to their
toxic profile. These highly toxic anti-coagulants remain on the
market, however, due to the fact that there are no alternatives
yet. Therefore, there is a great need for substitutes. Evolve will
be the leader in controlling rats with fertility control, arriving
first in the Netherlands and in
the European Union," said Klaas
Lusthoff, CEO of Q-chem.
"Evolve is a non-biocidal product and does not fall under the
time- and money-consuming procedure of the European Biocidal
Product Directive (528/2012). Evolve undergoes a considerably less
complicated process of less toxic substances via the Veterinary
Product Directive in The
Netherlands. Q-chem has helped Senestech on this regulatory
procedure, and the registration is expected at the end of 2024,"
continued Mr. Lusthoff. "Evolve is perfectly suited for our
strategy and in our portfolio of products, and Q-chem is looking
forward to introducing Senestech products in Europe."
The agreement with Q-chem includes initial orders and annual
minimums and provides for Q-chem taking the lead on regulatory
approvals.
About SenesTech
We are committed to improving the health of the world by
humanely managing animal pest populations through fertility
control. We are experts in fertility control to manage animal pest
populations. We invented ContraPest, the only U.S.
EPA-registered contraceptive for male and female rats, and Evolve,
an EPA-designated minimum-risk contraceptive currently offered for
rats. ContraPest and Evolve fit seamlessly into all integrated pest
management programs, significantly improving the overall goal of
effective pest management. We strive for clean cities, efficient
businesses and happy households – with a product designed to be
humane, effective and sustainable.
For more information visit https://senestech.com/
About Q-chem
Q-chem is a leading company in pest control with biocidal,
non-biocidal and sustainable products, and sells these products for
professional- and non-professional use in The Netherlands. Q-chem also has specifically
non-biocidal products which are sold throughout Europe.
Safe Harbor Statement
This press release contains "forward-looking statements" within
the meaning of federal securities laws, and we intend that such
forward-looking statements be subject to the safe harbor created
thereby. Such forward-looking statements include, among others, our
belief that Q-chem is a perfect partner for SenesTech as we begin
our expansion into Europe, and
that Evolve™ fits into their portfolio perfectly; the belief
that Evolve will be a pioneer in controlling rats, arriving first
in the Netherlands in the European
Union; and our expectation that registration for Evolve in
The Netherlands will come at the
end of 2024; and the belief that Evolve is perfectly suited for
Q-chem's strategy and in its portfolio of products .
Forward-looking statements may describe future expectations, plans,
results or strategies and are often, but not always, made through
the use of words such as "believe," "may," "future," "plan,"
"will," "should," "expect," "anticipate," "eventually," "project,"
"estimate," "continuing," "intend" and similar words or phrases.
You are cautioned that such statements are subject to risks,
uncertainties and other factors that could cause actual results to
differ materially from those reflected by such forward-looking
statements. Such factors include, among others, the successful
commercialization of our products; market acceptance of our
products; our financial performance, including our ability to fund
operations; our ability to regain and maintain compliance with
Nasdaq's continued listing requirements; regulatory approval and
regulation of our products; and other factors and risks identified
from time to time in our filings with the Securities and Exchange
Commission, including our Annual Report on Form 10-K for the fiscal
year ended December 31, 2022. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. Except as
required by law, we do not undertake any obligation to publicly
update any forward-looking statements, whether as a result of the
receipt of new information, the occurrence of future events or
otherwise.
CONTACT:
Investors:
Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners,
LLC,
602-889-9700, senestech@lythampartners.com
Company:
Tom Chesterman, Chief Financial
Officer, SenesTech, Inc.,
928-779-4143 x825
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-announces-exclusive-distribution-agreement-for-evolve-soft-bait-in-the-netherlands-302062566.html
SOURCE SenesTech, Inc.